Delivering the depth and detail neurology deserves
Neurology therapies face some of the greatest hurdles to early diagnosis, access, and adoption. This infographic highlights how NorstellaLinQ captures what others miss—unlocking the full complexity of the patient journey so you can drive faster diagnosis, generate stronger evidence, position therapies more effectively, and deliver better outcomes for patients who need them most. Download the […]
Introducing Trigger Alerts
Claims data can’t tell you what’s actually happening with your patients—not why treatment changed, what the latest labs revealed, or whether a physician is considering switching therapies. This infographic explores how Trigger Alerts powered by NorstellaLinQ bring you closer to the patient, earlier in their journey, with the clarity your brand and sales teams need […]
Conference catch-up: Innovation, AI & the future of pharma deal-making
In this episode, we recap the key takeaways from BIO-Europe 2025, held in Milan, Italy, in March 2025, with Trajko Spasenovski, Vice President of Strategic Account Management at Evaluate, and Carolyn Hall, Senior Director of Content and Thought Leadership Marketing at Evaluate. After the conference, Citeline’s Managing Editor, Meredith Landry, spoke with them about their […]
Get closer to the patient than ever before with NorstellaLinQ EMR data
If you’re only using claims and national reference lab data, you’re overlooking critical insights—like specialty pharmacy fills, treatment modifications, and physician rationale—that reveal the real drivers behind prescribing behavior. This infographic explores how NorstellaLinQ EMR fills these gaps with structured and unstructured clinical data that helps you see more, understand faster, and act smarter. What’s […]
NorstellaLinQ: Targeting patients and fueling brand strategy with trigger alerts
In this use case, find out how MMIT, using NorstellaLinQ, helped a pharma company identify high-risk patients with Trigger Alerts.
Breaking barriers in rare disease drug development
Bringing rare disease treatments from pipeline to patient Rare diseases affect more than 395 million people worldwide, yet only 5% have an FDA-approved treatment. The challenges of small patient populations, regulatory complexities, and limited clinical data have historically slowed progress. But the landscape is changing. This infographic explores the key barriers in rare disease drug […]
Unstructured EMR data expands cohort identification by 1,500%
By using integrated EMR, lab and claims data, Panalgo was able to provide the manufacturer with a rich longitudinal history for all identified patients.
Powering unbiased outcomes research with longitudinal data
The Panalgo team linked its unstructured EMR data, powered by NorstellaLinQ, to its closed claims data for a comprehensive, unbiased analysis. Within eight weeks, the client had access to years of longitudinal arthroplasty data, representing both inpatient and outpatient procedures, to fuel its study.
Complex cohort identification fuels real-time HCP targeting
Learn how one manufacturer used integrated claims, lab, EMR and coverage data to identify newly diagnosed, early-stage cancer patients for just-in-time HCP targeting.
The greatest opportunities to enhance drug development in 2025
The pharma industry continues to persevere through talent shortages, supply chain disruptions, data challenges, and many more obstacles that are making it increasingly difficult to get life-saving treatments to patients. However, the thirst for innovation and drive to make a difference for patients around the world is what keeps this sector going. As we start […]